Items where Author is "Jenner, P."

Number of items: 23.
Article
  • Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosets. (2010) K. A. Stockwell, D. K. A. Scheller, L. A. Smith, S. Rose, Mahmoud M. Iravani, M. J. Jackson and P. Jenner
  • Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction. (2009) K. A. Stockwell, D. Scheller, S. Rose, M. J. Jackson, K. Tayarani-Binazir, Mahmoud M. Iravani, L. A. Smith, C. W. Olanow and P. Jenner
  • Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets. (2008) K. A. Stockwell, D. J. Virley, M. Perren, Mahmoud M. Iravani, M. J. Jackson, S. Rose and P. Jenner
  • MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome. (2006) Bai-Yun Zeng, Mahmoud M. Iravani, S. T. Lin, M. Irifune, M. Kuoppamaki, G. Al-Barghouthy, L. Smith, M. J. Jackson, S. Rose, A.D. Medhurst and P. Jenner
  • Pramipexole protects against MPTP toxicity in non-human primates. (2006) Mahmoud M. Iravani, C. O. Haddon, J. M. Cooper, P. Jenner and A. H. Schapira
  • 3-Nitrotyrosine-dependent dopaminergic neurotoxicity following direct nigral administration of a peroxynitrite but not a nitric oxide donor. (2006) Mahmoud M. Iravani, C. O. Haddon, S. Rose and P. Jenner
  • A relationship support service for people with learning disabilities. (2006) P. Jenner and T.M. Gale
  • Age-associated changes in protein oxidation and proteasome activities in rat brain: Modulation by antioxidants. (2005) M. M. A. El Mohsen, Mahmoud M. Iravani, J. P. E. Spencer, S. Rose, A. T. Fahim, T. M. K. Motawi, N. A. F. Ismail and P. Jenner
  • Unilateral pallidotomy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets exhibiting levodopa-induced dyskinesia. (2005) Mahmoud M. Iravani, S. Costa, G. Al-Bargouthy, M. J. Jackson, Bai-Yun Zeng, M. Kuoppamaki, J. A. Obeso and P. Jenner
  • The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. (2005) Mahmoud M. Iravani, Clement C. M. Leung, Mona Sadeghian, C. O. Haddon, Sarah Rose and P. Jenner
  • Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat. (2005) B. Dass, Mahmoud M. Iravani, C. Huang, J. Barsoum, T. M. Engber, A. Galdes and P. Jenner
  • A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets. (2005) Mahmoud M. Iravani, E. Syed, M. J. Jackson, L. C. Johnston, L. A. Smith and P. Jenner
  • Role of inducible nitric oxide synthase in N-methyl-D-aspartic acid-induced strio-nigral degeneration. (2004) Mahmoud M. Iravani, L. Liu, S. Rose and P. Jenner
  • Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms. (2004) M. Gu, Mahmoud M. Iravani, J.M. Cooper, Diane King, P. Jenner and A. H. V. Schapira
  • 3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates. (2003) Mahmoud M. Iravani, M. J. Jackson, M. Kuoppamaki, L. A. Smith and P. Jenner
  • Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. (2002) Mahmoud M. Iravani, K. Kashefi, P. Mander, S. Rose and P. Jenner
  • Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets. (2002) B. Dass, Mahmoud M. Iravani, M. J. Jackson, T. M. Engber, A. Galdes and P. Jenner
  • GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets. (2001) Mahmoud M. Iravani, S. Costa, M. J. Jackson, Banu C. Tel, C. Cannizzaro, R. K. B. Pearce and P. Jenner
  • Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets. (2001) S. Costa, Mahmoud M. Iravani, R. K. B. Pearce and P. Jenner
  • Other
  • Continuous vs pulsatile administration of rotigotine in rat and monkey models of Parkinson's disease: A comparison. (2008) D. K. A. Scheller, W. J. Schmidt, M. J. Jackson, U. Ruess, K. Stockwell, M. Heindl, Mahmoud M. Iravani, K. Tayarani-Binazir, S. Rose and P. Jenner
  • The effects of pallidotomy on motor function in MPTP-treated, L-DOPA primed common marmosets. (2004) S. S. Costa, Mahmoud M. Iravani, M. J. Jackson and P. Jenner
  • Ecstasy (3,4-Methylenedioxymethamphetamine) inhibits dyskinesia expression and normalises locomotor activity in parkinsonian primates. (2002) Mahmoud M. Iravani, M. J. Jackson, G. Al-Barghouthy, M. Kouppamaki and P. Jenner
  • The effect of unilateral pallidotomy on motor disability, and L-dopa-induced dyskinesia in parkinsonian marmosets. (2002) Mahmoud M. Iravani, S. Costa, M. J. Jackson, G. Al-Bargouthy and P. Jenner